8-K
filed January 14, 2022, 6:59 PM ET
ticker REVB
CIK 0001810560
M&A
confidence high
sentiment neutral
materiality 0.85
Revelation Biosciences (f/k/a Petra Acquisition) closes de-SPAC merger; new board appointed
REVELATION BIOSCIENCES, INC.
- Business combination of Petra Acquisition and Revelation Biosciences closed Jan 10, 2022; company renamed Revelation Biosciences.
- Holders of 3,480,362 Petra shares redeemed for ~$35.5M ($10.20/share); ~$7.6M escrowed, ~$4.2M released to company.
- Immediately post-closing: 12,944,213 common shares outstanding; 10,490,461 warrants and 460,706 RSUs outstanding.
- New board appointed: George Tidmarsh, James Rolke, Jennifer Carver, Jess Roper, Curt LaBelle; prior Petra directors/officers resigned.
- Petra ceased to be a shell company; common stock begins trading on Nasdaq under REVB, REVBU, REVBW.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Andreas Typaldos departed as Director at REVELATION BIOSCIENCES, INC..
- Action
- ceased serving
- Role
- Director
Exact text from the filing
each of Andreas Typaldos, David Dobkin, Anthony Hayes, Robert Nicholson, Barry Dennis and William Carson ceased serving as a director of Petra
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
William Carson departed as Director at REVELATION BIOSCIENCES, INC..
- Action
- ceased serving
- Role
- Director
Exact text from the filing
each of Andreas Typaldos, David Dobkin, Anthony Hayes, Robert Nicholson, Barry Dennis and William Carson ceased serving as a director of Petra
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Andreas Typaldos departed as Executive Officer at REVELATION BIOSCIENCES, INC..
- Action
- ceased serving
- Role
- Executive Officer
Exact text from the filing
Andreas Typaldos and Sean Fitzpatrick ceased serving as executive officers of Petra
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Anthony Hayes departed as Director at REVELATION BIOSCIENCES, INC..
- Action
- ceased serving
- Role
- Director
Exact text from the filing
each of Andreas Typaldos, David Dobkin, Anthony Hayes, Robert Nicholson, Barry Dennis and William Carson ceased serving as a director of Petra
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
David Dobkin departed as Director at REVELATION BIOSCIENCES, INC..
- Action
- ceased serving
- Role
- Director
Exact text from the filing
each of Andreas Typaldos, David Dobkin, Anthony Hayes, Robert Nicholson, Barry Dennis and William Carson ceased serving as a director of Petra
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Sean Fitzpatrick departed as Executive Officer at REVELATION BIOSCIENCES, INC..
- Action
- ceased serving
- Role
- Executive Officer
Exact text from the filing
Andreas Typaldos and Sean Fitzpatrick ceased serving as executive officers of Petra
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Barry Dennis departed as Director at REVELATION BIOSCIENCES, INC..
- Action
- ceased serving
- Role
- Director
Exact text from the filing
each of Andreas Typaldos, David Dobkin, Anthony Hayes, Robert Nicholson, Barry Dennis and William Carson ceased serving as a director of Petra
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert Nicholson departed as Director at REVELATION BIOSCIENCES, INC..
- Action
- ceased serving
- Role
- Director
Exact text from the filing
each of Andreas Typaldos, David Dobkin, Anthony Hayes, Robert Nicholson, Barry Dennis and William Carson ceased serving as a director of Petra
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.